LEMD1 also facilitates invasion and epithelial–mesenchymal transition (EMT) in oral squamous cell carcinoma, thyroid cancer and pancreatic cancer [8,10,11]. This evidence concerns the gene LEMD1 and familial pancreatic carcinoma.